Print

Print


AUSTRALIA: Biotech In Stem Cell Giveaway
Gosia Kaszubska

November 16, 2004

A MELBOURNE biotech company will offer scientists unconditional
access to a new embryonic stem-cell line in an effort to speed up
lifesaving medical research.

Stem Cell Sciences says it is the first time a human embryonic stem-
cell line has been made freely available to researchers worldwide,
without any commercial or intellectual property constraints.

A stem-cell line is based on a cell that can endlessly replicate
itself in a laboratory and can be used to make any kind of cell in
the human body.

Stem Cell Sciences chief executive Peter Mountford said restrictions
on the use of existing stem-cell lines were hindering research. "It
really is not appropriate that something that has been donated for
the good of mankind is controlled by any individual," he said.

Dr Mountford said the line, which cost about $100,000 to develop, was
well suited for research into treatment for Parkinson's disease and
diabetes.

The company planned to release five more stem-cell lines over the
next two years.

Dr Mountford admitted the company's motives were not wholly
altruistic, with hopes that its expertise in stem-cell lines will
give it an edge in attracting the world's brightest researchers for
collaborative work. "We want to further scientific research, but this
is also a commercial decision aimed at raising the profile of the
company," he said.

SOURCE: The Australian, Australia
http://tinyurl.com/5bnvx

* * *
Murray Charters <[log in to unmask]>
Please place this address in your address book
Please purge all others

Web site: Parkinsons Resources on the WWWeb
http://www.geocities.com/murraycharters

----------------------------------------------------------------------
To sign-off Parkinsn send a message to: mailto:[log in to unmask]
In the body of the message put: signoff parkinsn